Can B CORP (NASC) — SEC Filings

Q: What are the key financial highlights for Can B CORP?

Key financial highlights for Can B CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Can B CORP?

Key executives at Can B CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Can B CORP stock?

Risk factors for Can B CORP (NASC) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Can B CORP?

Forward-looking statements and predictions from Can B CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Can B CORP. Recent 10-Q filing on Nov 19, 2024. AI-decoded analysis of earnings, risk factors, and insider trades.

View Can B CORP on SEC EDGAR

Overview

Can B CORP (NASC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 19, 2024: Can B Corp filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Canbiola, Inc., operates in the wholesale drug proprietaries and druggists' sundries sector. Its principal business address is in Hicksville, NY. The filing covers the third quarter and the first nine

Sentiment Summary

Across 17 filings, the sentiment breakdown is: 1 bearish, 16 neutral. The dominant filing sentiment for Can B CORP is neutral.

Filing Type Overview

Can B CORP (NASC) has filed 3 10-Q, 2 SC 13G/A, 9 8-K, 1 10-Q/A, 1 10-K, 1 SC 13G with the SEC between Jan 2024 to Nov 2024.

Recent Filings (17)

Can B Corp Files 10-Q for Q3 2024 — 10-Q · Nov 19, 2024 Risk: medium
Can B Corp filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Canbiola, Inc., operates in the wholesale drug proprietaries
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Can B Corp. Files 8-K: Material Agreements, Delisting Notice, Officer Changes — 8-K · Oct 28, 2024 Risk: high
Can B Corp. (formerly Canbiola, Inc.) filed an 8-K on October 28, 2024, reporting several material events. These include entering into a material definitive agr
10-Q Filing — 10-Q · Aug 19, 2024
Can B Corp Files Q1 2024 10-Q/A — 10-Q/A · Jul 17, 2024 Risk: low
Can B Corp filed a 10-Q/A on July 17, 2024, for the period ending March 31, 2024. The filing includes financial data for the first quarter of 2024 and compares
Can B Corp. Reports Exit and Disposal Costs — 8-K · Jun 18, 2024 Risk: medium
On June 14, 2024, Can B Corp. reported costs associated with exit or disposal activities. The filing does not specify the exact dollar amount or nature of these
Can B Corp. Dismisses Auditor Marcum LLP — 8-K · May 31, 2024 Risk: low
Can B Corp. announced on May 24, 2024, that it has dismissed its certifying accountant, Marcum LLP. The company stated that the decision was not a result of any
Can B Corp Files Q1 2024 10-Q — 10-Q · May 20, 2024 Risk: medium
Can B Corp filed its 10-Q for the period ending March 31, 2024. The company, formerly known as Canbiola, Inc., operates in the wholesale drug proprietaries and
Can B Corp. Changes Independent Auditor — 8-K · May 6, 2024 Risk: low
Can B Corp. announced on May 6, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting fir
Can B Corp Files 2023 Annual Report on Form 10-K — 10-K · Apr 15, 2024 Risk: low
Can B Corp (NASC) filed a Annual Report (10-K) with the SEC on April 15, 2024. Can B Corp filed its 10-K report for the fiscal year ending December 31, 2023. Th
Can B Corp. Enters Financial Obligation — 8-K · Mar 21, 2024 Risk: medium
On February 29, 2024, Can B Corp. entered into a direct financial obligation. The company, formerly known as Canbiola, Inc., is incorporated in Florida and its
Can B Corp. Completes Asset Acquisition — 8-K · Mar 20, 2024 Risk: medium
On March 14, 2024, Can B Corp. completed the acquisition of assets from 07 Trade & Services. The filing does not disclose specific dollar amounts or further det
Can B Corp. Files 8-K for Undisclosed Event — 8-K · Mar 6, 2024 Risk: medium
On February 20, 2024, Can B Corp. (formerly Canbiola, Inc.) filed an 8-K to report an "Other Event." The filing does not contain specific details about the natu
Can B Corp Settles with Former CEO — 8-K · Mar 1, 2024 Risk: low
Can B Corp. announced on February 27, 2024, that it has entered into a settlement agreement with its former CEO, Michael McSweeney. The agreement resolves all o
SC 13G/A Filing — SC 13G/A · Feb 14, 2024
Clearthink Capital Takes 9.99% Stake in Can B Corp — SC 13G · Feb 8, 2024 Risk: medium
Clearthink Capital Partners, LLC, a Delaware-based investment firm, has disclosed a significant stake in Can B Corp (formerly Canbiola, Inc.), a wholesale drug
Can B Corp. Files 'Other Events' 8-K; No Major News — 8-K · Jan 16, 2024
Can B Corp. filed an 8-K on January 12, 2024, under the 'Other Events' category, indicating no specific material event like an acquisition or executive change.

Risk Profile

Risk Assessment: Of NASC's 13 recent filings, 1 were flagged as high-risk, 7 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Key Executives

Michael McSweeney
Delaware

Industry Context

Can B Corp operates within the wholesale drug and druggists' sundries sector, as indicated by its SIC code 5122.

Top Tags

financials (3) · 10-Q (2) · company-update (2) · corporate-governance (2) · auditor-change (2) · material-agreement (1) · delisting-notice (1) · officer-changes (1) · 10-Q/A (1) · amendment (1)

Key Numbers

Reporting Period End: 20240331 — Financial data pertains to this date.
Prior Year Period End: 20230331 — For comparative financial analysis.
Fiscal Period End: 20240331 — End date of the reporting period for the 10-Q
Filing Date: 20240520 — Date the 10-Q was filed with the SEC
Q1 2024 Period: 2024-01-01 to 2024-03-31 — First quarter of fiscal year 2024
Q1 2023 Period: 2023-01-01 to 2023-03-31 — First quarter of fiscal year 2023 for comparison
Fiscal Year End: 2023-12-31 — Conformed Period of Report
SEC File Number: 000-55753 — SEC File Number
SIC Code: 5122 — Standard Industrial Classification
Shares Beneficially Owned: 1,000,000 — Number of Common Stock shares of Can B Corp owned by Clearthink Capital Partners, LLC
Percentage of Class: 9.99% — Percentage of Can B Corp's Common Stock beneficially owned by Clearthink Capital Partners, LLC
Date of Event: February 5, 2024 — The date triggering the requirement to file this SC 13G statement

Forward-Looking Statements

{"claim":"Clearthink Capital Partners, LLC may seek to engage with Can B Corp's management regarding strategic direction or operational improvements.","entity":"Clearthink Capital Partners, LLC","targetDate":"Next 6-12 months","confidence":"medium"}
{"claim":"The increased institutional ownership could lead to greater market visibility and potentially attract other investors to Can B Corp.","entity":"Can B Corp","targetDate":"Next 3-6 months","confidence":"medium"}

Frequently Asked Questions

What are the latest SEC filings for Can B CORP (NASC)?

Can B CORP has 17 recent SEC filings from Jan 2024 to Nov 2024, including 9 8-K, 3 10-Q, 2 SC 13G/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of NASC filings?

Across 17 filings, the sentiment breakdown is: 1 bearish, 16 neutral. The dominant sentiment is neutral.

Where can I find Can B CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Can B CORP (NASC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Can B CORP?

Key financial highlights from Can B CORP's most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for NASC?

The investment thesis for NASC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Can B CORP?

Key executives identified across Can B CORP's filings include Michael McSweeney, Delaware.

What are the main risk factors for Can B CORP stock?

Of NASC's 13 assessed filings, 1 were flagged high-risk, 7 medium-risk, and 5 low-risk.

What are recent predictions and forward guidance from Can B CORP?

Recent forward-looking statements from Can B CORP include guidance on {"claim":"Clearthink Capital Partners, LLC may seek to engage with Can B Corp's management regarding strategic direction and 1 other predictions.